Alexander K. Arrow Insider Trading $PTIX Protagenic Therapeutics, Inc.\new
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander K. Arrow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander K. Arrow. Alexander K. Arrow is Director in BIOLASE, INC ($BIOL) and President and COO in BIOLASE, INC ($BIOL) and Chief Financial Officer in Atrinsic, Inc. ($ATRN).
Alexander K. Arrow in Protagenic Therapeutics, Inc.\new
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of Alexander K. Arrow: Chief Financial Officer
Holdings: 119,260 shares
Latest Transaction: Jun 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Alexander K. Arrow in Protagenic Therapeutics, Inc.\new
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 4.98 | 3,000 | 14,940 | 33,000 | |
| May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 120,260 | 119.3 K to 120.3 K (+0.84 %) |
| May 03 2021 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Buy | P | 2.29 | 1,000 | 2,290 | 119,260 | 118.3 K to 119.3 K (+0.85 %) |
| Jul 21 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 124,998 | 218,747 | 124,998 | |
| Feb 26 2020 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 307,497 | 538,120 | 307,497 | |
| Mar 25 2019 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.00 | 41,667 | 41,667 | 41,667 | |
| Oct 18 2017 | PTIX | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | A | 1.75 | 75,000 | 131,250 | 75,000 | |
| Jun 21 2016 | ATRN | Protagenic Therape ... | Arrow Alexander K. | Chief Financial Off ... | Grant | A | 1.25 | 140,000 | 175,000 | 358,260 | 218.3 K to 358.3 K (+64.14 %) |
| May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 18,260 | 22,825 | 118,260 | |
| May 10 2016 | ATRN | Atrinsic, Inc. | Arrow Alexander K. | Chief Financial Off ... | Option Exercise | P | 1.25 | 40,000 | 50,000 | 100,000 |
Page: 1